Walgreens to Stop Selling Abortion Pills by Mail in 20 States

Walgreens to Stop Selling Abortion Pills by Mail in 20 States

Walgreens to Stop , Selling Abortion Pills , by Mail in 20 States.

On March 2, one of America's largest pharmacies said it would not distribute abortion pills by mail in some states.

On March 2, one of America's largest pharmacies said it would not distribute abortion pills by mail in some states.

CBS reports that Walgreens confirmed the decision to stop dispensing Mifepristone, stating that the abortion drug will no longer be available in 20 states.

CBS reports that Walgreens confirmed the decision to stop dispensing Mifepristone, stating that the abortion drug will no longer be available in 20 states.

According to a letter dated February 1, Walgreens was warned by 20 attorneys general that the sale of abortion drugs would violate both state and federal laws.

According to a letter dated February 1, Walgreens was warned by 20 attorneys general that the sale of abortion drugs would violate both state and federal laws.

Last summer, following the overturning of Roe v.

Wade, Missouri was among several states to implement strict prohibitions on abortion.

.

Other states that Mifepristone will no longer be available in include Arkansas, Florida, Texas and West Virginia.

Other states that Mifepristone will no longer be available in include Arkansas, Florida, Texas and West Virginia.

We will only dispense in those jurisdictions where it is legal to do if we are certified, Walgreens, via statement.

CBS reports that over half of all abortions in the U.S. utilize Mifepristone.

For over 20 years, the FDA limited the dispensing of the drug due to safety concerns.

.

For over 20 years, the FDA limited the dispensing of the drug due to safety concerns.

.

Those restrictions were lifted amid the COVID pandemic as a means of eliminating the need for in-person appointments.

CBS reports that at least one lawsuit has been filed against the FDA, claiming the agency overstepped its authority in approving Mifepristone.

CBS reports that at least one lawsuit has been filed against the FDA, claiming the agency overstepped its authority in approving Mifepristone